Form 4 holding
Director
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 22,000
- Estimated value
- $1,254,660
- Report date
- 06 Aug 2025
- Price
- $57.03
- Ownership
- Direct
Douglas A. Treco - Director at CRISPR Therapeutics AG
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CRSP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Douglas A. Treco since 20 Aug 2025
Reported holdings for Douglas A. Treco in CRISPR Therapeutics AG
Form 4 holding
Director
CRISPR Therapeutics AG
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 13,000
- Estimated value
- Report date
- 05 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Douglas A. Treco in CRISPR Therapeutics AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.